Meanwhile, we divided HNSCC patients into four subgroups based on TP53 and TTN mutational status, and then analyzed the effect of risk score on the survival of HNSCC patients within each subgroup. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.